Allmed Medical Products Co.,Ltd (SHE:002950)
China
· Delayed Price · Currency is CNY 13.81
-0.35 (-2.47%)
Apr 29, 2026, 3:04 PM CST
SHE:002950 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2018 |
| Operating Revenue | 3,672 | 3,293 | 2,707 | 4,195 | 2,888 | Upgrade
|
| Other Revenue | - | 33.12 | 49.4 | 15.78 | 37.44 | Upgrade
|
| Revenue | 3,672 | 3,326 | 2,757 | 4,211 | 2,926 | Upgrade
|
| Revenue Growth (YoY) | 10.38% | 20.66% | -34.53% | 43.92% | -23.70% | Upgrade
|
| Cost of Revenue | 2,621 | 2,398 | 2,099 | 2,812 | 2,053 | Upgrade
|
| Gross Profit | 1,050 | 928.04 | 657.93 | 1,399 | 872.17 | Upgrade
|
| Selling, General & Admin | 368.38 | 374.65 | 386.38 | 446.53 | 367.52 | Upgrade
|
| Research & Development | 104.05 | 106.37 | 77.37 | 107.74 | 94.58 | Upgrade
|
| Other Operating Expenses | -16.92 | 10.49 | 13.82 | 26.47 | 19.13 | Upgrade
|
| Operating Expenses | 455.52 | 494.41 | 478.51 | 582.45 | 484.52 | Upgrade
|
| Operating Income | 594.9 | 433.64 | 179.42 | 816.21 | 387.65 | Upgrade
|
| Interest Expense | - | -25.53 | -31.87 | -35.47 | -17.18 | Upgrade
|
| Interest & Investment Income | - | 7.16 | 1.87 | 3.09 | 39.97 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 17.15 | -8.57 | -140.63 | 33.41 | Upgrade
|
| Other Non Operating Income (Expenses) | -29.27 | -1.27 | -2 | -6.3 | -6.34 | Upgrade
|
| EBT Excluding Unusual Items | 565.63 | 431.15 | 138.85 | 636.9 | 437.51 | Upgrade
|
| Gain (Loss) on Sale of Investments | -10.04 | -23.28 | -6.88 | -160.19 | 6.13 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.77 | 28.79 | -0.07 | 3.5 | 1.94 | Upgrade
|
| Asset Writedown | -247.34 | -9.14 | 0.5 | -16.8 | -0.12 | Upgrade
|
| Other Unusual Items | - | 26.87 | 36.65 | 21.49 | 59.79 | Upgrade
|
| Pretax Income | 309.02 | 454.39 | 169.04 | 484.9 | 505.49 | Upgrade
|
| Income Tax Expense | 51.87 | 85.59 | 64.83 | 80.26 | 73.53 | Upgrade
|
| Earnings From Continuing Operations | 257.15 | 368.8 | 104.22 | 404.64 | 431.96 | Upgrade
|
| Minority Interest in Earnings | -8.26 | -0.12 | 6.18 | 2.15 | -0.75 | Upgrade
|
| Net Income | 248.88 | 368.68 | 110.4 | 406.79 | 431.21 | Upgrade
|
| Net Income to Common | 248.88 | 368.68 | 110.4 | 406.79 | 431.21 | Upgrade
|
| Net Income Growth | -32.49% | 233.95% | -72.86% | -5.66% | -62.75% | Upgrade
|
| Shares Outstanding (Basic) | 619 | 625 | 633 | 633 | 632 | Upgrade
|
| Shares Outstanding (Diluted) | 619 | 625 | 633 | 633 | 632 | Upgrade
|
| Shares Change (YoY) | -0.99% | -1.33% | 0.02% | 0.17% | -0.05% | Upgrade
|
| EPS (Basic) | 0.40 | 0.59 | 0.17 | 0.64 | 0.68 | Upgrade
|
| EPS (Diluted) | 0.40 | 0.59 | 0.17 | 0.64 | 0.68 | Upgrade
|
| EPS Growth | -31.82% | 238.44% | -72.87% | -5.82% | -62.73% | Upgrade
|
| Free Cash Flow | 456.81 | 554.64 | 137.02 | 751.68 | 84.16 | Upgrade
|
| Free Cash Flow Per Share | 0.74 | 0.89 | 0.22 | 1.19 | 0.13 | Upgrade
|
| Dividend Per Share | - | 0.060 | 0.027 | 0.060 | 0.210 | Upgrade
|
| Dividend Growth | - | 122.22% | -55.00% | -71.43% | -76.14% | Upgrade
|
| Gross Margin | 28.61% | 27.90% | 23.87% | 33.22% | 29.81% | Upgrade
|
| Operating Margin | 16.20% | 13.04% | 6.51% | 19.38% | 13.25% | Upgrade
|
| Profit Margin | 6.78% | 11.08% | 4.00% | 9.66% | 14.74% | Upgrade
|
| Free Cash Flow Margin | 12.44% | 16.68% | 4.97% | 17.85% | 2.88% | Upgrade
|
| EBITDA | 831.92 | 661.52 | 403.43 | 1,008 | 532.77 | Upgrade
|
| EBITDA Margin | 22.66% | 19.89% | 14.64% | 23.95% | 18.21% | Upgrade
|
| D&A For EBITDA | 237.02 | 227.88 | 224 | 192.2 | 145.12 | Upgrade
|
| EBIT | 594.9 | 433.64 | 179.42 | 816.21 | 387.65 | Upgrade
|
| EBIT Margin | 16.20% | 13.04% | 6.51% | 19.38% | 13.25% | Upgrade
|
| Effective Tax Rate | 16.79% | 18.84% | 38.35% | 16.55% | 14.55% | Upgrade
|
| Revenue as Reported | - | 3,326 | 2,757 | 4,211 | 2,926 | Upgrade
|
| Advertising Expenses | - | 17.97 | 15.98 | - | 27.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.